Global Recombinant Human Coagulation VIIa Competitive Landscape Professional Research Report 2024

Research Summary

Recombinant Human Coagulation VIIa (rFVIIa) is a synthetic form of human activated factor VII, a protein essential for blood clotting. It is produced using recombinant DNA technology, allowing for the creation of a biologically active version of the clotting factor. rFVIIa is used in medical settings, particularly in hemophilia management. Individuals with hemophilia, a genetic disorder characterized by deficient or defective clotting factors, may receive rFVIIa as a therapeutic intervention to promote blood clotting and prevent excessive bleeding. Additionally, rFVIIa has been explored for its hemostatic effects in various clinical scenarios, including surgical procedures and trauma situations where conventional treatments may be insufficient. The recombinant form provides a safe and effective alternative to plasma-derived coagulation factors, reducing the risk of viral transmission and other complications associated with traditional blood products.

According to DIResearch's in-depth investigation and research, the global Recombinant Human Coagulation VIIa market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Recombinant Human Coagulation VIIa include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed, GENERIUM etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Recombinant Human Coagulation VIIa. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Recombinant Human Coagulation VIIa market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Recombinant Human Coagulation VIIa market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Recombinant Human Coagulation VIIa industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Recombinant Human Coagulation VIIa Include:

Novo Nordisk

LFB SA HEMA Biologics

AryoGen Pharmed

GENERIUM

Recombinant Human Coagulation VIIa Product Segment Include:

1 mg

2 mg

5 mg

8 mg

Recombinant Human Coagulation VIIa Product Application Include:

Congenital Hemophilia

Acquired Hemophilia

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Recombinant Human Coagulation VIIa Industry PESTEL Analysis

Chapter 3: Global Recombinant Human Coagulation VIIa Industry Porter's Five Forces Analysis

Chapter 4: Global Recombinant Human Coagulation VIIa Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Recombinant Human Coagulation VIIa Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Recombinant Human Coagulation VIIa Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Recombinant Human Coagulation VIIa Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Recombinant Human Coagulation VIIa Market Overview

1.1 Product Definition and Statistical Scope

1.2 Recombinant Human Coagulation VIIa Product by Type

1.2.1 Global Recombinant Human Coagulation VIIa Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 1 mg

1.2.3 2 mg

1.2.4 5 mg

1.2.5 8 mg

1.3 Recombinant Human Coagulation VIIa Product by Application

1.3.1 Global Recombinant Human Coagulation VIIa Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Congenital Hemophilia

1.3.3 Acquired Hemophilia

1.4 Global Recombinant Human Coagulation VIIa Market Revenue and Sales Analysis

1.4.1 Global Recombinant Human Coagulation VIIa Market Size Analysis (2019-2030)

1.4.2 Global Recombinant Human Coagulation VIIa Market Sales Analysis (2019-2030)

1.4.3 Global Recombinant Human Coagulation VIIa Market Sales Price Trend Analysis (2019-2030)

1.5 Recombinant Human Coagulation VIIa Market Development Status and Trends

1.5.1 Recombinant Human Coagulation VIIa Industry Development Status Analysis

1.5.2 Recombinant Human Coagulation VIIa Industry Development Trends Analysis

2 Recombinant Human Coagulation VIIa Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Recombinant Human Coagulation VIIa Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Recombinant Human Coagulation VIIa Market Analysis by Regions

4.1 Recombinant Human Coagulation VIIa Overall Market: 2023 VS 2024 VS 2030

4.2 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Recombinant Human Coagulation VIIa Revenue and Market Share by Region (2019-2024)

4.2.2 Global Recombinant Human Coagulation VIIa Revenue Forecast by Region (2025-2030)

4.3 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis (2019-2030)

4.3.1 Global Recombinant Human Coagulation VIIa Sales and Market Share by Region (2019-2024)

4.3.2 Global Recombinant Human Coagulation VIIa Sales Forecast by Region (2025-2030)

4.4 Global Recombinant Human Coagulation VIIa Sales Price Trend Analysis (2019-2030)

5 Global Recombinant Human Coagulation VIIa Market Size by Type and Application

5.1 Global Recombinant Human Coagulation VIIa Market Size by Type

5.1.1 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Recombinant Human Coagulation VIIa Market Size by Application

5.2.1 Global Recombinant Human Coagulation VIIa Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Recombinant Human Coagulation VIIa Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Recombinant Human Coagulation VIIa Market Size by Type

6.3.1 North America Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

6.3.2 North America Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

6.4 North America Recombinant Human Coagulation VIIa Market Size by Application

6.4.1 North America Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

6.4.2 North America Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

6.5 North America Recombinant Human Coagulation VIIa Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Recombinant Human Coagulation VIIa Market Size by Type

7.3.1 Europe Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

7.3.2 Europe Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

7.4 Europe Recombinant Human Coagulation VIIa Market Size by Application

7.4.1 Europe Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

7.4.2 ? Europe Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

7.5 Europe Recombinant Human Coagulation VIIa Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Recombinant Human Coagulation VIIa Market Size by Type

8.3.1 China Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

8.3.2 China Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

8.4 China Recombinant Human Coagulation VIIa Market Size by Application

8.4.1 China Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

8.4.2 China Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Type

9.3.1 APAC (excl. China) Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

9.4 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Application

9.4.1 APAC (excl. China) Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

9.5 APAC (excl. China) Recombinant Human Coagulation VIIa Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Recombinant Human Coagulation VIIa Market Size by Type

10.3.1 Latin America Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

10.3.2 Latin America Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

10.4 Latin America Recombinant Human Coagulation VIIa Market Size by Application

10.4.1 Latin America Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

10.4.2 Latin America Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

10.5 Latin America Recombinant Human Coagulation VIIa Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Recombinant Human Coagulation VIIa Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Type

11.3.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales by Type (2019-2030)

11.3.2 Middle East & Africa Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)

11.4 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Application

11.4.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales by Application (2019-2030)

11.4.2 Middle East & Africa Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)

11.5 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Recombinant Human Coagulation VIIa Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Recombinant Human Coagulation VIIa Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Recombinant Human Coagulation VIIa Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Recombinant Human Coagulation VIIa Average Sales Price by Manufacturers (2020-2024)

12.2 Recombinant Human Coagulation VIIa Competitive Landscape Analysis and Market Dynamic

12.2.1 Recombinant Human Coagulation VIIa Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Novo Nordisk Recombinant Human Coagulation VIIa Product Portfolio

13.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 LFB SA HEMA Biologics

13.2.1 LFB SA HEMA Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Portfolio

13.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 AryoGen Pharmed

13.3.1 AryoGen Pharmed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 AryoGen Pharmed Recombinant Human Coagulation VIIa Product Portfolio

13.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 GENERIUM

13.4.1 GENERIUM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 GENERIUM Recombinant Human Coagulation VIIa Product Portfolio

13.4.3 GENERIUM Recombinant Human Coagulation VIIa Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Recombinant Human Coagulation VIIa Industry Chain Analysis

14.2 Recombinant Human Coagulation VIIa Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Recombinant Human Coagulation VIIa Typical Downstream Customers

14.4 Recombinant Human Coagulation VIIa Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support